Global Cystic Fibrosis CF Therapeutics Market Report 2024

Cystic Fibrosis (CF) Therapeutics Global Market Report 2024 – By Drug Class (Pancreatic Enzyme Supplements, Mucolytic, Bronchodilators, CFTR Modulators), By Route Of Administration (Oral, Inhaled), By Treatment Method (Medication, Devices) – Market Size, Trends, And Global Forecast 2024-2033

Starting Price : $5000.00 | Pages : | Published : January 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request Sample
Request For Discount
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Cystic Fibrosis (CF) Therapeutics Market

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Cystic Fibrosis (CF) Therapeutics Market Definition and Segments

Cystic fibrosis (CF) therapeutics refers to medications that thin and facilitate coughing up lung mucus. It is an inherited disorder that causes severe damage to the lungs, digestive system, and other organs in the body.

The main drug classes for cystic fibrosis (CF) therapeutics are pancreatic enzyme supplements, mucolytics, bronchodilators and CFTR modulators. Pancreatic enzyme supplements refer to supplements produced by the pancreas and containing pancreatin or pancrelipase, which is a combination of lipase, amylase, and protease. There are two routes of administration such as oral and inhaled. It includes methods of cystic fibrosis treatment with medication and devices.

The cystic fibrosis (CF) therapeutics market covered in this report is segmented –

1) By Drug Class: Pancreatic Enzyme Supplements, Mucolytic, Bronchodilators, CFTR Modulators

2) By Route Of Administration: Oral, Inhaled

3) By Treatment Method: Medication, Devices

The cystic fibrosis (CF) therapeutics market size has grown rapidly in recent years. It will grow from $6.91 billion in 2023 to $7.63 billion in 2024 at a compound annual growth rate (CAGR) of 10.4%. The growth in the historic period can be attributed to advancements in targeted therapies, growing understanding of CF genetics, patient advocacy and awareness, government support for research, orphan drug designations, incentives for rare disease research.

The cystic fibrosis (CF) therapeutics market size is expected to see strong growth in the next few years. It will grow to $10.59 billion in 2028 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to rise in C patient population, regulatory approvals for novel therapies, focus on personalized medicine, increasing investment in biomarker research, expanded newborn screening programs, healthcare policy support. Major trends in the forecast period include expansion of CFTR modulators, gene editing technologies, early intervention strategies, improved diagnostic techniques, telehealth and remote monitoring, healthcare digitalization, chronic disease management.

Growing Patient Numbers Drive Momentum in Cystic Fibrosis Therapeutics Market

An increase in the number of patients suffering from cystic fibrosis is expected to propel the growth of the cystic fibrosis (CF) therapeutics market going forward. Cystic fibrosis (CF) is an inherited condition that severely harms the body's lungs, digestive system, and other organs. Cystic fibrosis therapeutics are used to treat cystic fibrosis disorder by making the mucus in the lungs thinner and easier to cough up. Thus, an increase in the number of patients suffering from cystic fibrosis is expected to boost the cystic fibrosis (CF) therapeutics market. For instance, in July 2022, according to a report shared by The Cystic Fibrosis (CF) Foundation, a US-based non-profit organization, there has been an upsurge in the number of people with cystic fibrosis, in 2022 cystic fibrosis affects almost 40,000 children and adults in the United States, and over 105,000 people worldwide have been diagnosed. Therefore, an increase in the number of patients suffering from cystic fibrosis is driving the growth of the cystic fibrosis (CF) therapeutics market.

Personalized Medicine And Targeted Therapies Reshape Cystic Fibrosis (CF) Treatment Landscape

An increasing focus on personalized medicine and targeted therapies is expected to propel the growth of the cystic fibrosis (CF) therapeutics market going forward. Personalized medicine, or personalized care, refers to the method by which medical professionals study patients' unique genes, proteins, and other bodily components to provide and organize customized care through the use of precision medicine. Personalized medicine helps in the understanding of the genetic mutations that cause cystic fibrosis in detail to offer customized treatment plans based on each patient's unique genetic profile as the genetic basis of cystic fibrosis (CF) becomes clear. For instance, according to The Scope and Significance of Progress in 2022 report by the Personalized Medicine Coalition, a US-based professional membership organization, in 2022, the US Food and Drug Administration (FDA) approved 12 personalized medicines, which accounted for approximately 34% of all newly approved therapeutic molecular entities. Therefore, an increasing focus on personalized medicine and targeted therapies is driving the growth of the cystic fibrosis (CF) therapeutics market.

Major companies operating in the cystic fibrosis (CF) therapeutics market report are Teva Pharmaceutical Industries Ltd., F. Hoffmann-La Roche AG, Vertex Pharmaceuticals Incorporated, Chiesi Farmaceutici SpA, PTC Therapeutics LIMITED, Genentech Inc., Alaxia, AstraZeneca, Beyond Air Inc., Pfizer Inc., Alcresta Therapeutics Inc., Laurent Pharmaceuticals, Nestlé HealthScience, Vivus, Pharmaxis, Genentech, Bayer AG, Eli Lilly and Company, AbbVie Inc., Novartis AG, Arcturus Therapeutics Holdings Inc., Arrowhead Pharmaceuticals Inc., ProQR Therapeutics N.V., Enterprise Therapeutics Ltd., Corbus Pharmaceuticals Holdings Inc., Eloxx Pharmaceuticals, Translate Bio Inc., Arcturus Therapeutics Holdings Inc., Arrowhead Pharmaceuticals Inc., Zambon S.p.A .

Chiesi USA Introduces Groundbreaking Bronchitol For Cystic Fibrosis

Product innovations are a key trend gaining popularity in the cystic fibrosis (CF) therapeutics market. Major companies operating in the cystic fibrosis (CF) therapeutics sector are focused on developing new products to gain a competitive advantage in the market. For instance, in March 2021, Chiesi USA, a US-based specialty pharmaceutical company, launched Bronchitol (mannitol) powder, the ‘First and Only’ inhalation powder for cystic fibrosis patients. It is the only dry-powder inhaled mucoactive agent that is small, covert, and transportable, does not need to be refrigerated, and does not need to be cleaned frequently.

CF Foundation's Investment Accelerates Innovation In Cystic Fibrosis (CF) Therapeutics

Major companies operating in the cystic fibrosis (CF) therapeutics market are focused on investing to expand their footprints and strengthen their position in the market. Strategic investment in medical research describes the deliberate and organized distribution of funds, labor, and knowledge into scientific research projects with the goals of expanding our knowledge of medical disorders, creating novel treatments, and enhancing healthcare procedures. In January 2023, the Cystic Fibrosis Foundation (CF Foundation), a US-based non-profit organization that supports a broad range of research initiatives to cure cystic fibrosis, announced a strategic investment of up to $15 million in ReCode Therapeutics, a US-based clinical-stage genetic medicines and biotechnology company that uses superior delivery to power the next wave of messenger ribonucleic acid (mRNA) and gene correction therapeutics. ReCode will use the funds to develop its inhaled mRNA-based therapeutic for people with cystic fibrosis (CF), including those with genotypes that do not respond to approved cystic fibrosis transmembrane conductance regulator (CFTR) modulators.

CF Foundation And Flagship Pioneering Collaborated Targets Genetically Based Cystic Fibrosis Treatments

In November 2021, the Cystic Fibrosis Foundation (CF Foundation), a US-based non-profit organization that supports a broad range of research initiatives to cure cystic fibrosis, collaborated with Flagship Pioneering, a US-based life sciences venture capital company, through the Pioneering Medicines initiative to advance the development of genetically based treatments for cystic fibrosis. The Foundation plans to invest up to $110 million in the partnership as part of its Path to a Cure research agenda, with an initial commitment of $20 million. Pioneering Medicines will integrate technology from multiple flagship-founded businesses to create a distinct business devoted to investigating cystic fibrosis treatments.

North America was the largest region in the cystic fibrosis (CF) therapeutics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the cystic fibrosis (CF) therapeutics market during the forecast period. The regions covered in the cystic fibrosis (CF) therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the cystic fibrosis (CF) therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cystic fibrosis (CF) therapeutics market includes revenues earned by entities by providing services that include administration of mucus thinner, airway clearance, and antibiotics. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The cystic fibrosis therapeutics market research report is one of a series of new reports from The Business Research Company that provides cystic fibrosis therapeutics market statistics, including cystic fibrosis therapeutics industry global market size, regional shares, competitors with a cystic fibrosis therapeutics market share, detailed cystic fibrosis therapeutics market segments, market trends and opportunities, and any further data you may need to thrive in the cystic fibrosis therapeutics industry. This cystic fibrosis therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Cystic Fibrosis (CF) Therapeutics Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $7.63 billion
Revenue Forecast In 2033 $10.59 billion
Growth Rate CAGR of 8.6% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Drug Class: Pancreatic Enzyme Supplements, Mucolytic, Bronchodilators, CFTR Modulators
2) By Route Of Administration: Oral, Inhaled
3) By Treatment Method: Medication, Devices
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled Teva Pharmaceutical Industries Ltd.; F. Hoffmann-La Roche AG; Vertex Pharmaceuticals Incorporated; Chiesi Farmaceutici SpA; PTC Therapeutics LIMITED; Genentech Inc.; Alaxia; AstraZeneca; Beyond Air Inc.; Pfizer Inc.; Alcresta Therapeutics Inc.; Laurent Pharmaceuticals; Nestlé HealthScience; Vivus; Pharmaxis; Genentech; Bayer AG; Eli Lilly and Company; AbbVie Inc.; Novartis AG; Arcturus Therapeutics Holdings Inc.; Arrowhead Pharmaceuticals Inc; ProQR Therapeutics N.V.; Enterprise Therapeutics Ltd. ; Corbus Pharmaceuticals Holdings Inc; Eloxx Pharmaceuticals ; Translate Bio Inc; Arcturus Therapeutics Holdings Inc.; Arrowhead Pharmaceuticals Inc. ; Zambon S.p.A
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Cystic Fibrosis (CF) Therapeutics Market Characteristics

    3. Cystic Fibrosis (CF) Therapeutics Market Trends And Strategies

    4. Cystic Fibrosis (CF) Therapeutics Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On the Market

    4.2. Ukraine-Russia War Impact On the Market

    4.3. COVID-19 Impact On the Market

    5. Global Cystic Fibrosis (CF) Therapeutics Market Size and Growth

    5.1. Global Cystic Fibrosis (CF) Therapeutics Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Cystic Fibrosis (CF) Therapeutics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Cystic Fibrosis (CF) Therapeutics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Cystic Fibrosis (CF) Therapeutics Market Segmentation

    6.1. Global Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Pancreatic Enzyme Supplements

    Mucolytic

    Bronchodilators

    CFTR Modulators

    6.2. Global Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Oral

    Inhaled

    6.3. Global Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Medication  

    Devices

    7. Cystic Fibrosis (CF) Therapeutics Market Regional And Country Analysis

    7.1. Global Cystic Fibrosis (CF) Therapeutics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Cystic Fibrosis (CF) Therapeutics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market  

    8.1. Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market Overview  

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Cystic Fibrosis (CF) Therapeutics Market  

    9.1. China Cystic Fibrosis (CF) Therapeutics Market Overview  

    9.2. China Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Cystic Fibrosis (CF) Therapeutics Market  

    10.1. India Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Cystic Fibrosis (CF) Therapeutics Market  

    11.1. Japan Cystic Fibrosis (CF) Therapeutics Market Overview  

    11.2. Japan Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Cystic Fibrosis (CF) Therapeutics Market  

    12.1. Australia Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Cystic Fibrosis (CF) Therapeutics Market  

    13.1. Indonesia Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Cystic Fibrosis (CF) Therapeutics Market  

    14.1. South Korea Cystic Fibrosis (CF) Therapeutics Market Overview  

    14.2. South Korea Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Cystic Fibrosis (CF) Therapeutics Market  

    15.1. Western Europe Cystic Fibrosis (CF) Therapeutics Market Overview

    15.2. Western Europe Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Cystic Fibrosis (CF) Therapeutics Market  

    16.1. UK Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Cystic Fibrosis (CF) Therapeutics Market  

    17.1. Germany Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Cystic Fibrosis (CF) Therapeutics Market  

    18.5. France Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.6. France Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.7. France Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Cystic Fibrosis (CF) Therapeutics Market  

    19.9. Italy Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.10. Italy Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.11. Italy Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Cystic Fibrosis (CF) Therapeutics Market  

    20.13. Spain Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.14. Spain Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.15. Spain Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Cystic Fibrosis (CF) Therapeutics Market  

    21.1. Eastern Europe Cystic Fibrosis (CF) Therapeutics Market Overview

    21.2. Eastern Europe Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Cystic Fibrosis (CF) Therapeutics Market  

    22.1. Russia Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Cystic Fibrosis (CF) Therapeutics Market  

    23.1. North America Cystic Fibrosis (CF) Therapeutics Market Overview

    23.2. North America Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Cystic Fibrosis (CF) Therapeutics Market  

    24.1. USA Cystic Fibrosis (CF) Therapeutics Market Overview

    24.2. USA Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Cystic Fibrosis (CF) Therapeutics Market  

    25.1. Canada Cystic Fibrosis (CF) Therapeutics Market Overview

    25.2. Canada Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Cystic Fibrosis (CF) Therapeutics Market  

    26.1. South America Cystic Fibrosis (CF) Therapeutics Market Overview

    26.2. South America Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Cystic Fibrosis (CF) Therapeutics Market  

    27.1. Brazil Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Cystic Fibrosis (CF) Therapeutics Market  

    28.1. Middle East Cystic Fibrosis (CF) Therapeutics Market Overview

    28.2. Middle East Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Cystic Fibrosis (CF) Therapeutics Market  

    29.1. Africa Cystic Fibrosis (CF) Therapeutics Market Overview

    29.2. Africa Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Cystic Fibrosis (CF) Therapeutics Market Competitive Landscape And Company Profiles

    30.1. Cystic Fibrosis (CF) Therapeutics Market Competitive Landscape

    30.2. Cystic Fibrosis (CF) Therapeutics Market Company Profiles

    30.2.1. Teva Pharmaceutical Industries Ltd.

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. F. Hoffmann-La Roche AG

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Vertex Pharmaceuticals Incorporated

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Chiesi Farmaceutici SpA

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. PTC Therapeutics LIMITED

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Global Cystic Fibrosis (CF) Therapeutics Market Competitive Benchmarking

    32. Global Cystic Fibrosis (CF) Therapeutics Market Competitive Dashboard

    33. Key Mergers And Acquisitions In The Cystic Fibrosis (CF) Therapeutics Market

    34. Cystic Fibrosis (CF) Therapeutics Market Future Outlook and Potential Analysis

    34.1 Cystic Fibrosis (CF) Therapeutics Market In 2028 - Countries Offering Most New Opportunities

    34.2 Cystic Fibrosis (CF) Therapeutics Market In 2028 - Segments Offering Most New Opportunities

    34.3 Cystic Fibrosis (CF) Therapeutics Market In 2028 - Growth Strategies

    34.3.1 Market Trend Based Strategies

    34.3.2 Competitor Strategies

    35. Appendix

    35.1. Abbreviations

    35.2. Currencies

    35.3. Historic And Forecast Inflation Rates

    35.4. Research Inquiries

    35.5. The Business Research Company

    35.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Cystic Fibrosis (CF) Therapeutics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Cystic Fibrosis (CF) Therapeutics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Asia-Pacific, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: China, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: India, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: Japan, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Australia, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Indonesia, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: South Korea, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: Western Europe, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: UK, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: Germany, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: France, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: Italy, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Spain, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Eastern Europe, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Russia, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: North America, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: USA, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: Canada, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: South America, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: Brazil, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Middle East, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Africa, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Teva Pharmaceutical Industries Ltd. Financial Performance
  • Table 75: F. Hoffmann-La Roche AG Financial Performance
  • Table 76: Vertex Pharmaceuticals Incorporated Financial Performance
  • Table 77: Chiesi Farmaceutici SpA Financial Performance
  • Table 78: PTC Therapeutics LIMITED Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Cystic Fibrosis (CF) Therapeutics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Cystic Fibrosis (CF) Therapeutics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Asia-Pacific, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: China, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: India, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: Japan, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Australia, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Indonesia, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: South Korea, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: Western Europe, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: UK, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: Germany, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: France, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: Italy, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Spain, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Eastern Europe, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Russia, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: North America, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: USA, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: Canada, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: South America, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: Brazil, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Middle East, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Africa, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Cystic Fibrosis (CF) Therapeutics Market, Segmentation By Treatment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Teva Pharmaceutical Industries Ltd. Financial Performance
  • Figure 75: F. Hoffmann-La Roche AG Financial Performance
  • Figure 76: Vertex Pharmaceuticals Incorporated Financial Performance
  • Figure 77: Chiesi Farmaceutici SpA Financial Performance
  • Figure 78: PTC Therapeutics LIMITED Financial Performance
Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company
Read More
Global Gene Therapy Market 2022 – Market Opportunities And Strategies
Read More
The Microbiome Market Share, Market Size, And Growth Rate 2022
Read More
Latest TNF Alpha Inhibitors Market Growth Study 2022-2026 By The Business Research Company
Read More
The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the dermatitis market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the insulin drugs market research report 2022 with industry size, share, segments and market growth
Read More
Blood Cancer Drugs Global Market Report 2024 – By Blood Cancer Type (Leukemia, Lymphoma), By Drugs (Rituxan/Mabthera (Rituximab), Gleevec/Glivec (Imatinib), Revlimid (Lenalidomide), Velcade (Bortezomib), Tasigna (Nilotinib), Pomalyst (Pomalidomide), Vidaza (Azacitidine), Kyprolis (Carfilzomib), Adcetris (Brentuximab Vedotin), Other Drugs), By Treatment Approaches (Key Findings, Chemotherapeutic, mAbs/Targeted Therapies, Immunotherapeutic) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Cancer biologics Global Market Report 2024 – By Type (Monoclonal Antibodies, Vaccines, Cell And Gene Therapy, Other Types), By Application (Non-small Cell Lung Cancer, Prostate Cancer, Breast Cancer, Acute Myeloid Leukemia, Lymphoma, Multiple Myeloma, Ovarian Cancer, Colorectal Cancer, Gastric Cancers, Other Applications), By Distribution Channel (Hospitals, Clinics, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Rituximab Biosimilars Global Market Report 2024 – By Route Of Administration (Subcutaneous, Intravenous, Molecular Type), By Application (Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Rheumatoid Arthritis, Other Applications), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Mail Order) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Acute Myeloid Leukemia Global Market Report 2024 – By Treatment Type (Chemotherapy, Radiation therapy, Stem Cell Transplant, Targeted Therapy), By Chemotherapy (Cytarabine, Anthracycline Drugs, Alkylating Agents, Anti-metabolites, Tyrosine Kinase Inhibitors, Hormonal Therapy), By Regimen (DC Regimen, AVD Regimen, VCD Regimen), By End-User (Hospital, Retails Drug Stores, Ambulatory Care Centers, Clinics) – Market Size, Trends, And Global Forecast 2024-2033
View Report
CAR-T Therapy Global Market Report 2024 – By Type (Monotherapy, Combination Therapy), By Target Antigen (CD19, CD22, BCMA, Other Target Antigens), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Point-of-Care Diagnostics Devices And Equipment Global Market Report 2024 – By Type (Infectious disease testing kits, Cardio metabolic monitoring kits,, Cholesterol testing kits, Pregnancy and fertility tests kits, Tumor/cancer markers, Urinalysis testing kits, Hematology testing kits, Drugs of abuse testing kits, Fecal occult testing kits, Other Types), By Prescription Mode (Prescription-based Testing Devices, Over-The-Counter (OTC) Testing Devices), By End User (Professional diagnostic centers, Hospitals/critical care centers, Outpatient healthcare Setting, Ambulatory care settings, Research laboratories, Home) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Point-of-Care Diagnostics Devices And Equipment Global Market Report 2024 – By Type (Infectious disease testing kits, Cardio metabolic monitoring kits,, Cholesterol testing kits, Pregnancy and fertility tests kits, Tumor/cancer markers, Urinalysis testing kits, Hematology testing kits, Drugs of abuse testing kits, Fecal occult testing kits, Other Types), By Prescription Mode (Prescription-based Testing Devices, Over-The-Counter (OTC) Testing Devices), By End User (Professional diagnostic centers, Hospitals/critical care centers, Outpatient healthcare Setting, Ambulatory care settings, Research laboratories, Home) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Isothermal Nucleic Acid Amplification Technology (INAAT) Global Market Report 2024 – By Product (Instrument, Reagent), By Technology (NASBA, HAD), By Application (Blood Screening, Infectious Disease Diagnostics, Cancer), By End-User (Hospital, Reference Laboratories, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report

Frequently Asked Questions

What is the definition of the cystic fibrosis (CF) therapeutics market?

cystic fibrosis (CF) therapeutics refers to medications that thin and facilitate coughing up lung mucus. It is an inherited disorder that causes severe damage to the lungs, digestive system, and other organs in the body. For further insights on the cystic fibrosis (CF) therapeutics market, request a sample here

How will the cystic fibrosis (CF) therapeutics market drivers and restraints affect the cystic fibrosis (CF) therapeutics market dynamics? What forces will shape the cystic fibrosis (CF) therapeutics industry going forward?

The cystic fibrosis (CF) therapeutics market major growth driver - growing patient numbers drive momentum in cystic fibrosis therapeutics market. For further insights on the cystic fibrosis (CF) therapeutics market, request a sample here

What is the forecast market size or the forecast market value of the cystic fibrosis (CF) therapeutics market ?

The cystic fibrosis (CF) therapeutics market size has grown rapidly in recent years. It will grow from $6.91 billion in 2023 to $7.63 billion in 2024 at a compound annual growth rate (CAGR) of 10.4%. The growth in the historic period can be attributed to advancements in targeted therapies, growing understanding of cf genetics, patient advocacy and awareness, government support for research, orphan drug designations, incentives for rare disease research.. The cystic fibrosis (CF) therapeutics market size is expected to see strong growth in the next few years. It will grow to $10.59 billion in 2028 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to rise in cf patient population, regulatory approvals for novel therapies, focus on personalized medicine, increasing investment in biomarker research, expanded newborn screening programs, healthcare policy support.. Major trends in the forecast period include expansion of cftr modulators, gene editing technologies, early intervention strategies, improved diagnostic techniques, telehealth and remote monitoring, healthcare digitalization, chronic disease management.. For further insights on the cystic fibrosis (CF) therapeutics market, request a sample here

How is the cystic fibrosis (CF) therapeutics market segmented?

The cystic fibrosis (CF) therapeutics market is segmented
1) By Drug Class: Pancreatic Enzyme Supplements, Mucolytic, Bronchodilators, CFTR Modulators
2) By Route Of Administration: Oral, Inhaled
3) By Treatment Method: Medication, DevicesFor further insights on the cystic fibrosis (CF) therapeutics market, request a sample here

Which region has the largest share of the cystic fibrosis (CF) therapeutics market? What are the other regions covered in the report?

North America was the largest region in the cystic fibrosis (CF) therapeutics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the cystic fibrosis (CF) therapeutics market during the forecast period. The regions covered in the cystic fibrosis (CF) therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on the cystic fibrosis (CF) therapeutics market, request a sample here.

Who are the major players in the cystic fibrosis (CF) therapeutics market?

Major companies operating in the cystic fibrosis (CF) therapeutics market report are Teva Pharmaceutical Industries Ltd., F. Hoffmann-La Roche AG, Vertex Pharmaceuticals Incorporated, Chiesi Farmaceutici SpA, PTC Therapeutics LIMITED, Genentech Inc., Alaxia, AstraZeneca, Beyond Air Inc., Pfizer Inc., Alcresta Therapeutics Inc., Laurent Pharmaceuticals, Nestlé HealthScience, Vivus, Pharmaxis, Genentech, Bayer AG, Eli Lilly and Company, AbbVie Inc., Novartis AG, Arcturus Therapeutics Holdings Inc., Arrowhead Pharmaceuticals Inc, ProQR Therapeutics N.V., Enterprise Therapeutics Ltd. , Corbus Pharmaceuticals Holdings Inc, Eloxx Pharmaceuticals , Translate Bio Inc, Arcturus Therapeutics Holdings Inc., Arrowhead Pharmaceuticals Inc. , Zambon S.p.A . For further insights on the cystic fibrosis (CF) therapeutics market, request a sample here.

What are the key trends in the cystic fibrosis (CF) therapeutics market?

Major trend in the cystic fibrosis (CF) therapeutics market - chiesi usa introduces groundbreaking bronchitol for cystic fibrosis. For further insights on the cystic fibrosis (CF) therapeutics market, request a sample here.

What are the major opportunities in the cystic fibrosis (CF) therapeutics market? What are the strategies for the cystic fibrosis (CF) therapeutics market?

For detailed insights on the major opportunities and strategies in the cystic fibrosis (CF) therapeutics market, request a sample here.

How does the cystic fibrosis (CF) therapeutics market relate to the overall economy and other similar markets?

For detailed insights on cystic fibrosis (CF) therapeutics market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the cystic fibrosis (CF) therapeutics industry?

For detailed insights on the mergers and acquisitions in the cystic fibrosis (CF) therapeutics industry, request a sample here.

What are the key dynamics influencing the cystic fibrosis (CF) therapeutics market growth? SWOT analysis of the cystic fibrosis (CF) therapeutics market.

For detailed insights on the key dynamics influencing the cystic fibrosis (CF) therapeutics market growth and SWOT analysis of the cystic fibrosis (CF) therapeutics industry, request a sample here.